-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation